No Data
No Data
RBC Capital Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Raises Target Price to $131
RBC Capital analyst Leonid Timashev maintains $Axsome Therapeutics(AXSM.US)$ with a buy rating, and adjusts the target price from $130 to $131.According to TipRanks data, the analyst has a success
RBC Capital Reaffirms Their Buy Rating on Axsome Therapeutics (AXSM)
Needham Initiates Axsome Therapeutics(AXSM.US) With Buy Rating, Announces Target Price $130
Needham analyst Ami Fadia initiates coverage on $Axsome Therapeutics(AXSM.US)$ with a buy rating, and sets the target price at $130.According to TipRanks data, the analyst has a success rate of 47.4%
Express News | Axsome Therapeutics Inc : Needham Initiates Coverage With Buy Rating; Target Price $130
Axsome Therapeutics' AXS-05 Shows Promising Results in Treatment-resistant Depression
Decoding 9 Analyst Evaluations For Axsome Therapeutics
Axsome Therapeutics (NASDAQ:AXSM) has been analyzed by 9 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.The table below summarizes their recent
No Data
Salmon Klein : are you in $Macrogenics (MGNX.US)$ ? tell me when good to jump in
MangoXXXX Salmon Klein: Now
Stoic Trader Salmon Klein: Do your own research , I think hovering in bottom and buy signal from pattern about to begin , do not follow me blindly my
![grin 😁](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f601.png)
![+1 👍](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f44d-1f3fb.png)
Salmon Klein Stoic Trader: I am waiting to reach 14.8 or so, but I am busy working, if it reached the bottom and you are in...any good feedback is always very welcomed bro...just that so thanks
Stoic Trader Salmon Klein: Double higher bottom in intra-day might not hit below 14ish or if so still chance for 2 more trading sideways days, I am almost 25% down ( reason holding beyond top) anyway![+1 👍](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f44d-1f3fb.png)